Luigino Calzetta
- Emerging anti-inflammatory strategies for COPDBy Mario Cazzola, Clive P. Page, Luigino Calzetta and M. Gabriella MateraMario Cazzola*Dept of System Medicine, Unit of Respiratory Clinical Pharmacology, University of Rome “Tor Vergata”#Dept of Pulmonary Rehabilitation, San Raffaele Pisana Hospital, IRCCS, RomeClive P. Page¶Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UKLuigino Calzetta#Dept of Pulmonary Rehabilitation, San Raffaele Pisana Hospital, IRCCS, RomeM. Gabriella Matera+Dept of Experimental Medicine, Unit of Pharmacology, Second University of Naples, Naples, Italy
- Late-breaking abstract: Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaBy Christopher Hewson, Sheena Patel, Luigino Calzetta, Hinnah Campwala, Suzanne Havard, Emma Luscombe, Philip Clarke, Peter Peachell, Maria Matera, Mario Cazzola, Clive Page, William Abraham, Cara Williams, James Clark, Nicholas Clarke and Michael YeadonChristopher Hewson1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomSheena Patel1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomLuigino Calzetta2Unit of Respiratory Clinical Pharmacology, Dept. Internal Medicine, University of Rome “Tor Vergata”, Rome, ItalyHinnah Campwala1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomSuzanne Havard3Academic Unit of Respiratory Medicine, University of Sheffield, Sheffield, S Yorks, United KingdomEmma Luscombe1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomPhilip Clarke1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomPeter Peachell3Academic Unit of Respiratory Medicine, University of Sheffield, Sheffield, S Yorks, United KingdomMaria Matera4Unit of Pharmacology, Dept. Experimental Medicine, Second University of Naples, Naples, ItalyMario Cazzola2Unit of Respiratory Clinical Pharmacology, Dept. Internal Medicine, University of Rome “Tor Vergata”, Rome, ItalyClive Page5Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomWilliam Abraham6Dept. Research, Mount Sinai Medical Center, Miami Beach, FL, United StatesCara Williams7Inflammation & Immunity Research Unit, Pfizer, Cambridge, MA, United StatesJames Clark7Inflammation & Immunity Research Unit, Pfizer, Cambridge, MA, United StatesNicholas Clarke1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United KingdomMichael Yeadon1Allergy & Respiratory Research Unit, Pfizer, Sandwich, Kent, United Kingdom
- Emerging anti-inflammatory strategies for chronic obstructive pulmonary diseaseBy Mario Cazzola, Clive P. Page, Luigino Calzetta and Maria G. MateraArticle | Published in 2012 in European Respiratory JournalMario CazzolaClive P. PageLuigino Calzetta
- COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patientsBy Paola Rogliani, Luigino Calzetta, Francesco Romeo, Saverio Muscoli, Maria Gabriella Matera and Mario CazzolaPaola Rogliani1Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalyLuigino Calzetta2Department of Respiratory Rehabilitation, San Raffaele Pisana Hospital, IRCCS, Rome, ItalyFrancesco Romeo1Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalySaverio Muscoli1Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalyMaria Gabriella Matera3Department of Experimental Medicine, Second University of Naples, Naples, ItalyMario Cazzola1Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, Italy
- Long-lasting interaction study between RPL554 and glycopyrronium bromide on human isolated bronchiBy Luigino Calzetta, Mario Cazzola, Clive Page, Paola Rogliani, Francesco Facciolo and Maria Gabriella MateraLuigino Calzetta1Department of Respiratory Rehabilitation, San Raffaele Pisana Hospital, IRCCS, Rome, ItalyMario Cazzola2Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalyClive Page3Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King’s College London, London, United KingdomPaola Rogliani2Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalyFrancesco Facciolo4Thoracic Surgery, Regina Elena National Cancer Institute, Rome, ItalyMaria Gabriella Matera5Department of Experimental Medicine, Second University of Naples, Naples, Italy
- Translational study searching for synergy between glycopyrronium and indacaterolBy Mario Cazzola, Luigino Calzetta, Andrea Segreti, Francesco Facciolo, Paola Rogliani and Maria Gabriella MateraMario Cazzola1Department of System Medicine, University of Rome "Tor Vergata", Rome, ItalyLuigino Calzetta2Department of Respiratory Rehabilitation, San Raffaele Pisana Hospital, IRCCS, Rome, ItalyAndrea Segreti1Department of System Medicine, University of Rome "Tor Vergata", Rome, ItalyFrancesco Facciolo3Thoracic Surgery, Regina Elena National Cancer Institute, Rome, ItalyPaola Rogliani1Department of System Medicine, University of Rome "Tor Vergata", Rome, ItalyMaria Gabriella Matera4Department of Experimental Medicine, Second University of Naples, Naples, Italy
- Interaction between RPL554 and glycopyrronium bromide in small human airwaysBy Luigino Calzetta, Mario Cazzola, Clive Page, Paola Rogliani, Francesco Facciolo and Maria Gabriella MateraLuigino Calzetta1Department of Respiratory Rehabilitation, San Raffaele Pisana Hospital, IRCCS, Rome, ItalyMario Cazzola2Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalyClive Page3Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King’s College London, London, United KingdomPaola Rogliani2Department of System Medicine, University of Rome ‘Tor Vergata’, Rome, ItalyFrancesco Facciolo4Thoracic Surgery, Regina Elena National Cancer Institute, Rome, ItalyMaria Gabriella Matera5Department of Experimental Medicine, Second University of Naples, Naples, Italy
- Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysisBy Mario Cazzola, Luigino Calzetta, Clive Page, Josè Jardim, Alexander G. Chuchalin, Paola Rogliani and Maria Gabriella MateraMario Cazzola1Dept of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyLuigino Calzetta1Dept of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyClive Page2Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UKJosè Jardim3Respiratory Diseases, Escola Paulista de Medicina of Federal University of Sao Paulo, Sao Paulo, BrazilAlexander G. Chuchalin4Institute of Pulmonology, Federal Medical and Biological Agency, Moscow, RussiaPaola Rogliani1Dept of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyMaria Gabriella Matera5Dept of Experimental Medicine, Second University of Naples, Naples, Italy
- Effects of the new ultra-long-acting β2-AR agonist indacaterol in chronic treatment alone or in combination with the β1-AR blocker metoprolol on cardiac remodellingBy Luigino Calzetta, Barbara Rinaldi, Maria Donniacuo, Eugenio Martuscelli, Augusto Orlandi and Maria Gabriella MateraLuigino Calzetta1Department of System Medicine, University of Rome "Tor Vergata", Rome, ItalyBarbara Rinaldi2Department of Experimental Medicine, Second University of Naples, Naples, ItalyMaria Donniacuo2Department of Experimental Medicine, Second University of Naples, Naples, ItalyEugenio Martuscelli1Department of System Medicine, University of Rome "Tor Vergata", Rome, ItalyAugusto Orlandi3Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyMaria Gabriella Matera2Department of Experimental Medicine, Second University of Naples, Naples, Italy
- Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPDBy Josuel Ora, Luigino Calzetta, Paola Rogliani, Chiara Ciaprini, Rosamaria Capuano, Eugenio Martinelli, Roberto Paolesse, Corrado Di Natale and Mario CazzolaJosuel Ora1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyLuigino Calzetta1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyPaola Rogliani1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyChiara Ciaprini1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyRosamaria Capuano2Department of Electronic Engineering, University of Rome "Tor Vergata", Rome, ItalyEugenio Martinelli2Department of Electronic Engineering, University of Rome "Tor Vergata", Rome, ItalyRoberto Paolesse3Department of Chemical Science and Technology, University of Rome "Tor Vergata", Rome, ItalyCorrado Di Natale2Department of Electronic Engineering, University of Rome "Tor Vergata", Rome, ItalyMario Cazzola1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy
- Effect of simvastatin on steroid-resistence in human epithelial cultured cells: A preliminary studyBy Luigino Calzetta, Barbara Rinaldi, Giuseppe Gritti, Maria Donniacuo, Giovanna Donnarumma and Maria Gabriella MateraLuigino Calzetta1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyBarbara Rinaldi2Department of Experimental Medicine, Second University of Naples, Naples, ItalyGiuseppe Gritti2Department of Experimental Medicine, Second University of Naples, Naples, ItalyMaria Donniacuo2Department of Experimental Medicine, Second University of Naples, Naples, ItalyGiovanna Donnarumma2Department of Experimental Medicine, Second University of Naples, Naples, ItalyMaria Gabriella Matera2Department of Experimental Medicine, Second University of Naples, Naples, Italy
- Searching for synergistic interaction between aclidinium (ACL) and formoterol (FOR): From bench to bedsideBy Luigino Calzetta, Josuel Ora, Paola Rogliani, Maria Gabriella Matera and Mario CazzolaLuigino Calzetta1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyJosuel Ora1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyPaola Rogliani1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, ItalyMaria Gabriella Matera2Department of Experimental Medicine, Second University of Naples, Naples, ItalyMario Cazzola1Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy
- Onset of action of aclidinium (ACL), glycopyrronium (GLY) and tiotropium (TIO): A comparison in COPD patientsBy Paola Rogliani, Roberto Lipsi, Josuel Ora, Gabriella Lucà, Luigino Calzetta and Mario CazzolaPaola RoglianiDepartment of System Medicine, University of Rome "Tor Vergata", Rome, ItalyRoberto LipsiDepartment of System Medicine, University of Rome "Tor Vergata", Rome, ItalyJosuel OraDepartment of System Medicine, University of Rome "Tor Vergata", Rome, ItalyGabriella LucàDepartment of System Medicine, University of Rome "Tor Vergata", Rome, ItalyLuigino CalzettaDepartment of System Medicine, University of Rome "Tor Vergata", Rome, ItalyMario CazzolaDepartment of System Medicine, University of Rome "Tor Vergata", Rome, Italy
- Cardiovascular Complications of Respiratory DisordersEdited by Miguel Ángel Martínez-García, Jean-Louis Pépin and Mario CazzolaBook | Published in 2020DOI: 10.1183/2312508X.erm8820ISBN (electronic): 978-1-84984-119-1Miguel Ángel Martínez-GarcíaJean-Louis Pépin
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.